Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell of lymphatic vessel | 12 studies | 24% ± 8% | |
| type I pneumocyte | 6 studies | 26% ± 4% | |
| endothelial cell | 4 studies | 21% ± 7% | |
| type II pneumocyte | 4 studies | 26% ± 5% | |
| astrocyte | 4 studies | 25% ± 4% | |
| epithelial cell | 3 studies | 21% ± 4% | |
| retinal rod cell | 3 studies | 18% ± 2% | |
| club cell | 3 studies | 23% ± 4% | |
| ciliated cell | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of UBTD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 881.25 | 2622 / 2642 | 100% | 50.82 | 705 / 705 |
| skin | 100% | 2977.35 | 1809 / 1809 | 99% | 57.73 | 467 / 472 |
| thymus | 100% | 1203.74 | 651 / 653 | 99% | 60.29 | 600 / 605 |
| uterus | 100% | 1081.84 | 170 / 170 | 98% | 41.78 | 451 / 459 |
| adrenal gland | 100% | 787.07 | 257 / 258 | 98% | 30.94 | 226 / 230 |
| ovary | 98% | 634.36 | 176 / 180 | 100% | 74.00 | 430 / 430 |
| lung | 100% | 2386.64 | 577 / 578 | 98% | 47.46 | 1130 / 1155 |
| prostate | 100% | 1076.09 | 245 / 245 | 97% | 21.65 | 489 / 502 |
| breast | 100% | 1165.83 | 458 / 459 | 98% | 38.52 | 1091 / 1118 |
| kidney | 100% | 1392.64 | 89 / 89 | 97% | 29.26 | 875 / 901 |
| bladder | 100% | 944.86 | 21 / 21 | 96% | 32.34 | 482 / 504 |
| liver | 98% | 727.74 | 222 / 226 | 97% | 23.46 | 394 / 406 |
| esophagus | 98% | 734.11 | 1422 / 1445 | 97% | 24.43 | 177 / 183 |
| stomach | 92% | 557.12 | 329 / 359 | 90% | 20.23 | 257 / 286 |
| pancreas | 75% | 361.58 | 247 / 328 | 99% | 39.95 | 176 / 178 |
| intestine | 78% | 542.17 | 755 / 966 | 87% | 19.12 | 459 / 527 |
| eye | 0% | 0 | 0 / 0 | 100% | 55.75 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.18 | 29 / 29 |
| ureter | 0% | 0 | 0 / 0 | 100% | 64.83 | 1 / 1 |
| muscle | 100% | 1477.83 | 802 / 803 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1298.12 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 835.37 | 240 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1075.45 | 1322 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 1522.70 | 852 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 23.00 | 41 / 45 |
| peripheral blood | 78% | 1341.65 | 729 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005515 | Molecular function | protein binding |
| Gene name | UBTD1 |
| Protein name | Ubiquitin domain-containing protein 1 |
| Synonyms | |
| Description | FUNCTION: May be involved in the regulation of cellular senescence through a positive feedback loop with TP53. Is a TP53 downstream target gene that increases the stability of TP53 protein by promoting the ubiquitination and degradation of MDM2. . |
| Accessions | ENST00000370664.4 Q9HAC8 |